Shimada Akihiko, Aga Kenichiro, Shimada Ayako, Hosaka Miki, Shimada Shoji, Onishi Tatsuya, Yamachika Daisuke, Seki Hiroaki, Yasui Nobutaka, Matsumoto Hidetoshi
Dept. of Surgery, Keiyu Hospital, Japan.
Gan To Kagaku Ryoho. 2013 Jan;40(1):83-5.
A 74-year-old woman was referred to our hospital for a close examination. A gastrointestinal endoscopic examination revealed an advanced gastroesophageal junction cancer type 3, which was diagnosed as well-differentiated adenocarcinoma. Computed tomography(CT)showed liver and para-aortic lymph node metastases.She was treated with oral S-1 at 100mg/ day for 28 days, followed by a 14-day rest. After 3 courses of treatment, the primary tumor was greatly reduced. After 18 months of treatment, CT showed a complete response of the liver and also the para-aortic lymph node metastases. She is alive without severe adverse effects and recurrence 2.5 years after the start of S-1 administration.
一名74岁女性因需要进行详细检查而被转诊至我院。胃肠内镜检查显示为进展期3型胃食管交界癌,诊断为高分化腺癌。计算机断层扫描(CT)显示肝脏和主动脉旁淋巴结转移。给予患者口服S-1,每日100mg,服用28天,随后休息14天。经过3个疗程的治疗,原发肿瘤明显缩小。治疗18个月后,CT显示肝脏及主动脉旁淋巴结转移灶完全缓解。自开始服用S-1起2.5年后,她仍然存活,且无严重不良反应及复发。